129 results on '"Lee, I.-Ling"'
Search Results
2. Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial
3. Merits of using chromosome representations and shadow chromosomes in genetic algorithms for solving scheduling problems
4. Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
5. Self-destructive behaviour among Taiwanese young people
6. Data from Identification of Genes Correlated with Early-Stage Bladder Cancer Progression
7. Supplementary Table 1 from Identification of Genes Correlated with Early-Stage Bladder Cancer Progression
8. Supplementary Table 2 from Identification of Genes Correlated with Early-Stage Bladder Cancer Progression
9. Data from Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
10. Supplementary Figures 1 through 4 from Salivary Auto-Antibodies as Noninvasive Diagnostic Markers of Oral Cavity Squamous Cell Carcinoma
11. Supplementary Tables 1 and 2 from Salivary Auto-Antibodies as Noninvasive Diagnostic Markers of Oral Cavity Squamous Cell Carcinoma
12. Supplementary Figures S1-S3 from Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
13. Association of DNA damage response (DDR) gene mutations (mts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients (pts) enrolled onto SWOG S1314.
14. S1314 correlative analysis of ATM, RB1, ERCC2, and FANCC mutations and pathologic complete response (pT0) at cystectomy after neoadjuvant chemotherapy (NAC) in patients with muscle invasive bladder cancer (MIBC): Implications for bladder preservation.
15. IN VITRO EFFECTS OF INTERFERON ALPHA IN BLADDER CANCER: IMMUNE CHECKPOINT EXPRESSION AND MICRORNA AND MRNA GENOMIC PROFILING: MP83-12
16. In situ iron activated persulfate oxidative fluid sparging treatment of TCE contamination — A proof of concept study
17. Forced COX-2 expression induces PGE 2 and invasion in immortalized urothelial cells
18. Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Disrupts Urothelial Differentiation
19. IDENTIFICATION OF DISTINCT BASAL AND LUMINAL SUBSETS OF HUMAN BLADDER CANCERS WITH DIFFERENT SENSITIVITIES TO FRONTLINE CHEMOTHERAPY: MP61-07
20. Hiding in Plain View: Genetic Profiling Reveals Decades Old Cross Contamination of Bladder Cancer Cell Line KU7 with HeLa
21. Characterization of a Panel of Cell Lines Derived From Urothelial Neoplasms: Genetic Alterations, Growth In Vivo and the Relationship of Adenoviral Mediated Gene Transfer to Coxsackie Adenovirus Receptor Expression
22. Quercetin and its metabolites improve vessel function by inducing eNOS activity via phosphorylation of AMPK
23. Abstract PR09: Gene expression profiling in wild-type and mutant FGFR3 metastatic urothelial cancer treated with combination therapy with vofatamab and pembrolizumab
24. Abstract 3093: Prognostic value of novel immune basal subtypes in muscle invasive bladder cancer
25. MP38-06 IDENTIFICATION OF NOVEL IMMUNE BASAL SUBTYPES IN MUSCLE INVASIVE BLADDER CANCER
26. SMOOTH MUSCLE MYOSIN HEAVY CHAINS ARE DEVELOPMENTALLY REGULATED IN THE RABBIT BLADDER
27. Abstract 3689: Identification of candidate therapeutic targets in BCG unresponsive bladder cancer- inflammatory subtypes of BCG unresponsive bladder cancer
28. Abstract 995: Impact of molecular subtypes on predicting chemotherapy response and survival in muscle invasive bladder cancer
29. A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer
30. MP83-12 IN VITRO EFFECTS OF INTERFERON ALPHA IN BLADDER CANCER: IMMUNE CHECKPOINT EXPRESSION AND MICRORNA AND MRNA GENOMIC PROFILING
31. Impacts of Autophagy-Inducing Ingredient of Areca Nut on Tumor Cells
32. Salivary Auto-Antibodies as Noninvasive Diagnostic Markers of Oral Cavity Squamous Cell Carcinoma
33. MP61-07 IDENTIFICATION OF DISTINCT BASAL AND LUMINAL SUBSETS OF HUMAN BLADDER CANCERS WITH DIFFERENT SENSITIVITIES TO FRONTLINE CHEMOTHERAPY
34. Corrigendum to “Quercetin and its metabolites improve vessel function by inducing eNOS activity via phosphorylation of AMPK” [Biochem. Pharmacol. 84 (2012) 1036–1044]
35. A STAT3- and p63-dependent transcriptional network to define a lethal basal subset of human bladder cancers.
36. The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells
37. p63 expression correlates with sensitivity to the Eg5 inhibitor AZD4877 in bladder cancer cells
38. Abstract LB-472: p63 inhibits epithelial - mesenchymal transition by promoting the expression of miR205 in human bladder cancer cells
39. p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers
40. Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
41. Abstract 4861: Identification of premalignant bladder markers using DNA microarray analysis of the UPII-SV40Tag model for invasive bladder UCC
42. Identification of Genes Correlated with Early-Stage Bladder Cancer Progression
43. Abstract A16: DNA microarray analysis of the UPII‐SV40Tag model for invasive bladder TCC: Identification of markers for bladder premalignancy
44. EFFECTS OF MTOR INHIBITOR EVEROLIMUS (RAD001) ON BLADDER CANCER CELLS
45. Forced COX-2 expression induces PGE2 and invasion in immortalized urothelial cells
46. Abstract B52: Identification of genes involved in early stage bladder cancer progression.
47. Scientist versus Practitioner–An abridged meta-analysis of the changing role of psychologists
48. Persulfate oxidation of trichloroethylene with and without iron activation in porous media
49. 618: Identification of Apoptosis and Cell Cycle Related Genes Induced by Connexin-26 Expression in Human Bladder Cancer Cell Lines
50. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.